Safety and Immunogenicity of ChimeriVax-WN02 West Nile Vaccine in Healthy Adults

Clinical trial NCT00442169 · COMPLETED

Trial details

NCT number: NCT00442169
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

West Nile Fever

Start date: 2005-12-01
Primary completion: 2008-06-01
Enrollment: 208

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.